Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Exercise × Myeloid × Clear all

Phase

Status

Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 14 Lymphoid 8 Gastrointestinal 7 Other hematologic neoplasm 6 Genitourinary 6 Tumor-Agnostic 4 Thoracic 3 Other 2 Head & Neck 2 Gynecologic 2 Dermatologic 2 CNS 2 Plasma cell 1 Myeloid 1 Classical hematology 1

Conditions

Myelodysplastic Syndromes 1 Cytopenia 1

Interventions

fludarabine 32 Cyclophosphamide 27 venetoclax 25 Azacitidine 24 Specimen Handling 23 Biopsy 20 Cytarabine 16 fludarabine phosphate 15 ruxolitinib 13 Whole-Body Irradiation 13 Melphalan 12 Stem Cell Transplantation 11 Injections 11 Decitabine 11 Busulfan 11 Tacrolimus 10 Mycophenolic Acid 8 asciminib 7 Thiotepa 7 Methotrexate 7 Granulocyte Colony-Stimulating Factor 7 decitabine and cedazuridine drug combination 6 Magnetic Resonance Spectroscopy 6 Idarubicin 6 Hematopoietic Stem Cell Transplantation 6 nilotinib 5 X-Rays 5 Filgrastim 5 Daunorubicin 5 Dasatinib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06773871 2025-08-19

HemEx

Rigshospitalet, Denmark

Phase NA Recruiting

Classical hematologyMyeloid

Cytopenia, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon ⚡